Cabergoline
Composition
The formulation contains Cabergoline as the active ingredient.
Indications
Hyperprolactinemia, pituitary adenomas, and Parkinson's disease
Side effects
Nausea, dizziness, hypotension
Precautions
Monitor for signs of valvular heart disease and psychiatric symptoms.
Contraindications
Hypersensitivity to Cabergoline or any component, uncontrolled hypertension, history of fibrotic disorders.
Dosage and administration
As directed by healthcare provider
Countries
Worldwide
Available Forms
Tablets